GDNF and amyotrophic lateral sclerosis: In conclusion, given the progress that has been made in the delivery of secreted proteins into the CNS, with GDNF for ALS and Parkinson’s disease as an example, it may be an ideal time to more actively revisit neurotrophic factors for the treatment of ALS.